Vascular hypertrophy and insulin resistance have been associated with abnormal left ventricular (LV) geometry in population studies. We wanted to investigate the influence of vascular hypertrophy and insulin resistance on LV hypertrophy and its function in patients with hypertension. In 89 patients with essential hypertension and electrocardiographic LV hypertrophy, we measured blood pressure; insulin sensitivity by hyperinsulinaemic euglucaemic clamp; minimal forearm vascular resistance (MFVR) by plethysmography; intima-media crosssectional area of the common carotid arteries (IMA) by ultrasound; and LV mass, relative wall thickness (RWT), systolic function and diastolic filling by echocardiography after two weeks of placebo treatment. LV mass index correlated to IMA/height (r ¼ 0.36, P ¼ 0.001), serum insulin (r ¼ À0.25, Po0.05), plasma glucose (r ¼ À0.34, Po0.01), and showed a tendency towards a correlation to insulin sensitivity (r ¼ 0.21, P ¼ 0.051), but was unrelated to MFVR. Deceleration time of early diastolic transmitral flow positively correlated to IMA/ height (r ¼ 0.30, Po0.01). The ratio between early and atrial LV filling peak flow velocity negatively correlated to MFVR men (r ¼ À0.30, Po0.05). Endocardial and midwall systolic LV function were not related to vascular hypertrophy, plasma glucose, serum insulin or insulin sensitivity. In conclusion, insulin resistance was not related to LV hypertrophy or reduced LV function. However, high thickness of the common carotid arteries was associated with LV hypertrophy and high deceleration time of early diastolic transmitral flow. High MFVR was associated with low ratio between early and atrial LV filling peak flow velocity. This may suggest that systemic vascular hypertrophy contributes to abnormal diastolic LV relaxation in patients with hypertension and electrocardiographic LV hypertrophy.
Vascular hypertrophy and insulin resistance have been associated with abnormal left ventricular (LV) geometry in population studies. We wanted to investigate the influence of vascular hypertrophy and insulin resistance on LV hypertrophy and its function in patients with hypertension. In 89 patients with essential hypertension and electrocardiographic LV hypertrophy, we measured blood pressure; insulin sensitivity by hyperinsulinaemic euglucaemic clamp; minimal forearm vascular resistance (MFVR) by plethysmography; intima-media crosssectional area of the common carotid arteries (IMA) by ultrasound; and LV mass, relative wall thickness (RWT), systolic function and diastolic filling by echocardiography after two weeks of placebo treatment. LV mass index correlated to IMA/height (r ¼ 0.36, P ¼ 0.001), serum insulin (r ¼ À0.25, Po0.05), plasma glucose (r ¼ À0.34, Po0.01), and showed a tendency towards a correlation to insulin sensitivity (r ¼ 0.21, P ¼ 0.051), but was unrelated to MFVR. Deceleration time of early diastolic transmitral flow positively correlated to IMA/ height (r ¼ 0.30, Po0.01). The ratio between early and atrial LV filling peak flow velocity negatively correlated to MFVR men (r ¼ À0.30, Po0.05). Endocardial and midwall systolic LV function were not related to vascular hypertrophy, plasma glucose, serum insulin or insulin sensitivity. In conclusion, insulin resistance was not related to LV hypertrophy or reduced LV function. However, high thickness of the common carotid arteries was associated with LV hypertrophy and high deceleration time of early diastolic transmitral flow. High MFVR was associated with low ratio between early and atrial LV filling peak flow velocity. This may suggest that
Introduction
Left ventricular (LV) hypertrophy is associated with hypertension, and has been associated with vascular hypertrophy, in some studies even independent of blood pressure indicating a direct relation between cardiac and vascular hypertrophy.
1,2 LV hypertrophy has been hypothesized to be associated with insulin resistance. 3 The association between LV function, vascular hypertrophy and insulin resistance has not been investigated in detail. Since cardiac afterload is dependent on the compliance of the conduit arteries 4 and peripheral vascular resistance, 5 impaired systolic LV function might be related to central as well as peripheral vascular hypertrophy. Since insulin resistance and hyperinsulinaemia have been associated with increased vascular hypertrophy 6 and stiffness, 7 insulin resistance might also be associated with increased cardiac stiffness compromising diastolic LV filling.
We aimed, therefore, to investigate the association between insulin resistance, hypertrophy of the conduit arteries and remodelling of the small peripheral arteries on the one hand, and LV hypertrophy, diastolic LV filling and systolic LV function on the other, in placebo-treated patients with essential hypertension and electrocardiographic LV hypertrophy.
Methods

Subjects
In the 'Insulin Carotids US Scandinavia' (ICARUS) substudy, 7 we included 99 patients with essential hypertension and left ventricular hypertrophy determined by screening electrocardiogram prior to study entry. All patients included in the clinical trial Losartan Intervention for Endpoint-reduction in hypertension (LIFE) 8 met the study's inclusion and exclusion criteria, and were investigated after two weeks of placebo treatment. The protocol was approved by the local Ethics Committee and written informed consent acquired. In all, 89 of the patients had an echocardiography performed as part of the echocardiographic substudy of LIFE. The ICARUS study group consists of investigators from the Department of Internal Medicine, The University of Michigan Medical Center, USA; Department of Internal Medicine, Glostrup University Hospital, Copenhagen, Denmark; Department of Internal Medicine, Ullevaal University Hospital, Oslo, Norway; The Clinical Research Group of Oregon, Oregon, USA, and The Mount Sinai Medical Center, New York, USA. In total, 10 patients had diabetes mellitus and 22 had newly diagnosed hypertension. Patient characteristics are listed in Tables 1 and 2 .
Protocol and methods
The patients were investigated on three days, and all measurements were taken with the patient in the supine position in a quiet room with a constant temperature of 24-271C.
Blood pressures
According to the protocol of the LIFE study sitting blood pressure was measured at the time of randomization using a manual mercury sphygmomanometer. In connection with the isoglycaemic clamp and the ultrasound investigation of the carotid arteries resting blood pressure was measured with the patient in the supine position using a manual mercury sphygmomanometer or a semiautomatic sphygmomanometer (Dinamap F Model 1846 SX, Critikon, Johnson & Johnson Medical Inc., USA). The patients recruited at different centres had comparable sitting blood pressures at randomization. Based on the blood pressures measured at the three separate occasions mean values for systolic and mean arterial blood pressure were calculated. These mean values were comparable in the different centres and were used in all the correlations.
Ultrasound of the common carotid arteries IMT and the lumen diameter of the common carotid arteries were measured by ultrasound using the ACUSON 128XP/10c (Acuson Corporation, Mountain View, CA, USA) and a linear 7 MHz transducer (L7). IMT of the right the and the left common carotid artery were measured in the 1-cm segment proximal to the dilation of the carotid bulb as described by Howard et al 9 in the ARIC study. The longitudinal B-mode image was accepted as valid when a double line resembling laminae media and intima was visualized in the longest possible segment. At end-diastole IMT of the far walls of the left as well as of the right common carotid artery were measured at 10 points 1 mm apart and the mean value was calculated. The end-diastolic and end-systolic lumen diameter of the right as well as the left common carotid artery were measured using M-mode within the 1-cm segment proximal to the dilation of the carotid bulb avoiding measuring at a visible atherosclerotic plaque. Carotid distensibility was calculated for both arteries as the relative change in lumen diameter divided by the pulse pressure at the time of the investigation, and the mean value was calculated. All readings were done on digitized pictures (Optimas 6.11, Optimas Corporation, Bothell, WA, USA) at The University of Michigan Medical Center by a technician who did not know the patients or the purpose of the study.
Isoglycaemic hyperinsulinaemic clamp
A polyethylene cannula was inserted into an antecubital vein in each arm, one for intermittent collection of blood samples and one for infusion.
After half an hour of rest the blood pressures were measured. A 2-h isoglycaemic hyperinsulinaemic clamp was performed according to the principles described by DeFronzo et al. 10 To achieve high yet physiological insulin levels, 11 insulin (Velosuline, Novo Nordic, Denmark) was infused for 2 h at a rate of 50 mU/m 2 /min. Isoglycaemia was maintained by infusion of glucose (200 g/l). Infusion rate was adjusted in response to plasma glucose concentrations. Insulin sensitivity was calculated from the data obtained during the last 20 min of the clamp. The insulin sensitivity was assessed by (1) the whole body glucose uptake (M) calculated as the rate of glucose infusion (GINF) per kg body weight (M ¼ GINF/weight) and (2) by the whole body glucose uptake index (M/IG) calculated as the rate of GINF per kg body weight divided by the plasma level of glucose and insulin in the last 20 min of the clamp (M/IG ¼ GINF/(weightninsulinnglucose)). Glucose uptake was normalized for 'metabolic size' by dividing with body weight, 12 and, when using the glucose uptake index, the glucose uptake was also normalized for the influence of the ambient glucose level 13 at high insulin levels, 14 and related to the actual plasma level of insulin by dividing with the plasma concentration of glucose and insulin.
Minimal forearm vascular resistance (MFVR)
Maximal forearm blood flow was measured after 10 min of ischaemia 15 using strain gauge plethysmography (Model EC5R. Hokanson, Inc., Bellevue, WA, USA). 16 Forearm blood flow was measured 6-10 times during the first minute of hyperaemia and expressed as ml flow per 100 ml tissue per min. In the same period, blood pressure was measured three times as described. The highest forearm blood flow measurement during the first minute of hyperaemia was taken as the maximal forearm blood flow. MFVR was calculated as mean blood pressure divided by the maximal forearm blood flow (mmHg/(ml/ minn100 ml)). Owing to higher level and greater variance of MFVR in women compared to men, we analysed MFVR data separately in men and women.
Echocardiography
An echocardiogram was performed following a previously validated protocol. 17 Standardized examinations included 2-D guided M-mode echocardiograms and selected 2-D recordings. Studies were performed using a high-quality commercially available echocardiograph (VingMed CFM-800, General Electric) equipped with 3.0-3.5 and 2.0-2.5 MHz probes and Super-VHS video recorder. Measurements were made blindly at the Echocardiography Reading Center at The Presbyterian Hospital-Weill Medical College of Cornell University in New York City by experienced physician readers using computerized review stations (Digisonics, Inc., Houston, TX, USA) equipped with digitizing tablet and monitor screen overlay for calibration and performance of each needed measurement. LV dimensions were measured according to recommendations of the American Society of Echocardiography. When optimal orientation of the LV or atrial imaging views could not be obtained, correctly oriented two-dimensional linear dimension measurements were made by the leading-edge convention. End-diastolic LV diameter and wall thickness were used to calculate the total wall thickness (septum and posterior wall), relative wall thickness (RWT) and LV mass by a formula that gives values closely related to autopsy LV weight (r ¼ 0.90) and that showed excellent reproducibility. 17 LV hypertrophy was considered to be present when LV mass index exceeded 116 g/m 2 for men and 104 g/m 2 for women, and increased RWT was present when this ratio exceeded 0.43. Based on these cutoff values the patients were categorized as having normal geometry, concentric remodelling (increased RWT), eccentric hypertrophy (increased LV mass index, but normal RWT) or concentric hypertrophy (increased LV mass index and RWT).
From LV internal dimension in diastole and systole, LV endocardial as well as midwall fractional shortening were calculated correcting for differences in relative wall thickness. 18 Stress-corrected endocardial and midwall fractional shortening were derived as the ratio between the observed and predicted shortening. 18 As a measure of myocardial afterload circumferential end-systolic stress was estimated at the midwall from M-mode tracings using a cylindrical model described by Gaasch et al. 19 Stroke volume was calculated by the invasively validated aortic annular leading-edge method (aortic annular cross-sectional area Â Doppler time-velocity integral of annular flow) 20 and used to calculate the cardiac output.
Pulsed Doppler recordings of the transmitral flow velocities were obtained between the tips of the mitral valves, measuring early and atrial LV filling peak flow velocity as well as deceleration time of early diastolic transmitral flow. Pulse Doppler recordings were obtained from LV outflow tract, and the isovolumetric relaxation time was measured from the closure spike of the aortic valve to the onset of the mitral flow. 21 Measurements up to three cycles were averaged. LV filling patterns were classified by a modification of the approach of Appleton et al 22 : (a) LV filling was considered normal when isovolumetric relaxation time was o100 ms, deceleration time between 150 and 250 ms and ratio between early and atrial LV filling peak flow velocity between 1.0 and 1.5. (b) Abnormal relaxation 23 was identified by prolonged isovolumetric relaxation time (4100 ms) and by prolonged deceleration time (4250 ms) as well as by reduced ratio between early and atrial LV filling peak flow velocity (o1.0). (c) Pseudonormal filling pattern was recognized by the combination of prolonged isovolumetric relaxation time (4100 ms) and normal deceleration time as well as normal ratio between early and atrial LV filling peak flow velocity. (d) Restrictive filling pattern was identified by short or normal isovolumetric relaxation time (o100 ms), by reduced deceleration time (o150 ms) and by high ratio between early and atrial LV filling peak flow velocity 41.5.
Assays
Plasma glucose concentrations were measured using a Beckmann glucose analyzer (Beckman Instruments Inc., Fullerton, CA, USA) and a glucose oxidase method. Serum insulin concentrations were determined by enzyme immunoassay, as described by Andersen et al. 24 
Statistics
Parametric statistics were used calculating mean values, standard deviations and 95% confidence intervals as most parameters were normally distributed. When comparing groups, unpaired two-tailed t-test was used. Simple linear regression analyses and stepwise, backward multiple linear regression analyses were performed. P-values of less than 0.05 were considered statistically significant. Statistica 5.1 (StatSoft, Inc., Tulsa, OK, USA) was used for data management and statistical analyses.
Results
Although the women were smaller and had smaller hearts and blood vessels than the men, the metabolic and functional parameters were almost independent of gender (Tables 1 and 2 ). Abnormal LV geometry was found in 69 out of 89 patients (78%) consisting of six patients with concentric remodelling, 49 with eccentric hypertrophy and 14 with concentric hypertrophy. Cardiovascular hypertrophy measured as LV mass index (r ¼ 0.21, Po0.05), cross-sectional area of intima-media thickness indexed by height (r ¼ 0.27, Po0.01) and MFVR men (r ¼ À0.28, Po0.05) were all positively related to systolic blood pressure. Internal end-diastolic diameter, LV mass and LV mass index ( Figure 1) were positively correlated to hypertrophy of the common carotid artery, but were not significantly related to MFVR (Table 3) . LV mass index was negatively correlated to plasma RWT was independent of both metabolic and vascular parameters (Table 3 ) leaving these parameters equal within the four geometric subgroups.
Systolic LV function assessed by either endocardial or midwall fractional shortening was not related to plasma glucose, serum insulin, insulin sensitivity, diabetes or vascular parameters (Table 3) . However, stroke volume negatively correlated to serum insulin (r ¼ À0.34, Po0.01). Circumferential end-systolic stress negatively correlated to serum insulin (r ¼ À0.25, Po0.05) and positively to insulin sensitivity (r ¼ 0.24, Po0.05). However, in multiple regression analyses these relations were not independent of the relation between LV mass index, insulin and insulin sensitivity. Stroke volume (r ¼ 0.29, Po0.01) and circumferential end-systolic stress (r ¼ 0.27, P ¼ 0.01) positively correlated to IMA/height, but not independent of the relation between IMA/height and LV mass index. Cardiac output (r ¼ À0.31, Po0.05) and circumferential endsystolic stress (r ¼ 0.35, Po0.01) correlated to MFVR men . In multiple regression analyses including systolic blood pressure the relation between circumferential end-systolic stress and MFVR men was not independent of the relation between MFVR men and systolic blood pressure.
We were able to categorize 79 of the 89 patients according to diastolic LV filling parameters, and found that six patients had normal diastolic filling, 26 had abnormal relaxation, 25 had pseudonormal filling pattern and 22 had restrictive filling pattern. We did not find any significant metabolic or vascular differences between the groups (Table 4) . However, patients with pseudonormal filling pattern had insignificantly higher diastolic blood pressure, patients with abnormal relaxation had higher MFVR and IMT, and patients with normal relaxation had lower MFVR and higher plasma glucose (Table 4) . Using simple linear regression analyses the ratio between early and atrial LV filling peak flow velocity was found to be negatively correlated to MFVR men (r ¼ À0.30, Po0.05), and showed a tendency towards a positive correlation to plasma glucose (r ¼ 0.21, P ¼ 0.06) and serum insulin (r ¼ 0.21, P ¼ 0.06), but was unrelated to hypertrophy of the common carotid arteries, insulin sensitivity and diabetes. The isovolumetric relaxation time showed a tendency towards a positive correlation to IMT (r ¼ 0.22, P ¼ 0.06), but was unrelated to MFVR men , plasma glucose, serum insulin and insulin sensitivity. The deceleration time positively correlated to IMT (r ¼ 0.28, P ¼ 0.01), IMA/height (r ¼ 0.30, Po0.01) and the internal diameter of the common carotid arteries (r ¼ 0.24, Po0.05), but was unrelated to MFVR men , plasma glucose, serum insulin, insulin sensitivity and diabetes. The rather large number of relations tested in this study increase the risk of type 1 error; however, the consistency in the relation between different LV mass indices and carotid artery dimensions is convincing. The relation between deceleration time of the early diastolic transmitral flow and carotid artery dimensions is also consistent and thereby also likely to be correct.
Discussion
We found that LV hypertrophy, abnormal LV geometry and LV dysfunction were independent of insulin resistance and diabetes and that LV hypertrophy was associated with low plasma glucose and low serum insulin. This negative relation between LV hypertrophy and serum insulin was opposite of what we expected, but supportive of the already published negative relation between carotid hypertrophy and serum insulin. 7 The finding may be explained by the selection of hypertensive patients who have survived passed the age of 55 years, despite electrocardiographic LV hypertrophy creating bias against additional metabolic disturbances, because patients with both cardiovascular hypertrophy and metabolic disturbances were more likely to die before inclusion. 7 RWT and thereby LV geometry were independent of central and peripheral vascular hypertrophy, as well as insulin levels and insulin resistance.
LV hypertrophy was associated with high intimamedia thickness of the common carotid arteries, but was unrelated to high MFVR. The association between LV and carotid hypertrophy has been demonstrated by others, 25, 26 and may reflect parallel blood pressure-dependent cardiac and vascular changes and/or blood pressure-independent LV hypertrophy secondary to changes in compliance arteries. 1, 2 The lack of correlation between LV hypertrophy and peripheral vascular hypertrophy assessed by MFVR is somewhat controversial, because a significant relation was observed in a Danish subgroup of about 30 patients in which LV mass was measured by magnetic resonance imaging. 2 Since other groups have found a positive relation between LV mass and MFVR, 27, 28 this is probably because of the higher reproducibility of LV mass measured by magnetic resonance imaging.
Systolic LV function was independent of central and peripheral vascular changes as well as serum insulin, insulin sensitivity and diabetes. Hypertrophy of the common carotid arteries is associated with LV hypertrophy in these patients. Owing to the requirements of the main study, the patients were selected to have LV hypertrophy on electrocardiography and normal systolic function, making the possibility of detecting an association between reduced systolic LV function and LV hypertrophy as well as vascular hypertrophy very unlikely. Inspite of this, low cardiac output was associated with high MFVR men , which may reflect the importance of peripheral vascular hypertrophy for increased cardiac afterload. 5 Since the relation between high stroke volume and hypertrophy of the common carotid arteries was not independent of LV hypertrophy, the association between them might only confirm that patients with LV hypertrophy have larger LV volumes and thereby higher stroke volumes. The association between increased circumferential end-systolic stress and central as well as peripheral vascular hypertrophy was not independent of the systolic blood pressure and probably reflects parallel blood pressure-induced changes.
High deceleration time of the early diastolic transmitral flow was associated with hypertrophy of the common carotid arteries, and low ratio between early and atrial LV filling peak flow velocity was associated with high MFVR men . These relations did not remain significant when dividing the patients categorically according to diastolic filling patterns reflecting the fact that it is difficult to categorize patients based on continuous diastolic variables. Furthermore, we did not measure pulmonary vein flow, which may complicate the distinction between normal relaxation and pseudonormalization. There were no relations between diastolic LV function and plasma glucose, serum insulin, insulin resistance or diabetes. The association between systemic vascular hypertrophy and abnormal diastolic LV relaxation, defined as a relatively by early LV filling peak flow velocity with a slow deceleration, is interesting. In a Danish subgroup of these patients, we have previously demonstrated a relation between changes in myocardial flow reserve assessed by positron emission tomography and vascular changes in the forearm and in the carotid arteries. 29 The association between abnormal diastolic filling and vascular hypertrophy may, therefore, be explained by abnormal diastolic LV relaxation secondary to reduced myocardial flow reserve and relative myocardial ischaemia compromising diastolic LV filling.
Conclusion
In this selected group of hypertensive patients with electrocardiographic LV hypertrophy, we found evidence of parallel cardiac and vascular hypertrophy. Metabolic abnormalities did not seem to influence LV geometry, systolic or diastolic LV function. This suggests that at this stage of hypertension the blood pressure burden has overridden a possible influence of metabolic abnormalities on cardiovascular structure and function. Abnormal diastolic relaxation was associated with high IMA/ height as well as high MFVR indicating that systemic vascular hypertrophy may contribute to the compromised diastolic LV filling in patients with hypertension and electrocardiographic LV hypertrophy.
Limitations
All patients selected had hypertension and LV hypertrophy on electrocardiography, reducing the possibility of demonstrating any associations with LV mass. This, in fact, strengthens the associations shown between LV mass and IMA. The use of multiple-statistical comparisons increases the risk of finding false-positive associations. We have tried to compensate for this by evaluating alternative parameters together reducing the possibility of association by luck.
